NEW YORK, Nov. 8 (GenomeWeb News) - PerkinElmer said today that it has signed agreements to provide California with tandem mass spectrometry systems to support the state's expanded newborn screening program.
According to PerkinElmer, it will provide
PerkinElmer also said it will provide the state's contracted newborn screening laboratories with 17-OHP assay kits for the screening of congenital adrenal hyperplasia. The company expects this system will be available for sale in late 2004 or early 2005.
Additional terms of the arrangements were not disclosed.